2016
Barriers to participation in industry‐sponsored clinical trials in pediatric type 2 diabetes
Farrell R, Bethin K, Klingensmith G, Tamborlane WV, Gubitosi‐Klug R. Barriers to participation in industry‐sponsored clinical trials in pediatric type 2 diabetes. Pediatric Diabetes 2016, 18: 574-578. PMID: 27807915, DOI: 10.1111/pedi.12465.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAttitude of Health PersonnelChildDiabetes Mellitus, Type 2Drug ApprovalDrug IndustryDrugs, InvestigationalEndocrinologyHumansHyperglycemiaHypoglycemiaHypoglycemic AgentsInternetNeeds AssessmentPatient SelectionPediatricsRandomized Controlled Trials as TopicResearch PersonnelResearch Support as TopicSocieties, ScientificSurveys and QuestionnairesUnited StatesUnited States Food and Drug AdministrationWorkforceConceptsPediatric Endocrine SocietyType 2 diabetesClinical trialsPediatric endocrinologistsIndustry-sponsored clinical trialsPatients age 18 yearsPediatric type 2 diabetesCurrent glycemic controlNew T2D casesAdditional treatment optionsAge 18 yearsBaseline demographicsT2D patientsGlycemic controlMedication useMultiple medicationsPediatric patientsResearch nursesPediatric populationTreatment optionsEndocrine SocietyT2D casesDrug AdministrationVisit scheduleAnonymous online survey
2011
Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. The Journal Of Clinical Endocrinology & Metabolism 2011, 96: 2968-2979. PMID: 21976745, DOI: 10.1210/jc.2010-2756.Peer-Reviewed Original ResearchConceptsReal-time continuous glucose monitoringContinuous glucose monitoringStrength of recommendationsQuality of evidenceEndocrine SocietyPractice guidelinesEndocrine Society Clinical Practice GuidelineGrading of RecommendationsClinical practice guidelinesRisk of hypoglycemiaEvidence-based guidelinesEvidence-based recommendationsTask ForceAdult hospital settingsDiabetes Technology SocietyAdult outpatientsAdolescent outpatientsHospital settingGlucose monitoringEuropean SocietyOutpatientsGuidelinesTarget levelGroup meetingsGlycemia